Tepnel starts Construction of new state-of-the-art Scottish Laboratories
Tepnel Life Sciences PLC is beginning construction work on its new pharmaceutical testing facility in Livingston, Scotland. This laboratory will house Tepnel's protein analysis and genomic testing laboratories as well as the Company's analytical chemistry, bioanalysis and microbiology facilities.
The new facility is planned to come on stream in the second quarter of 2007 and will initially employ 42 people who are currently located at Tepnel's two existing Scottish facilities in Glasgow and Edinburgh. The new facility will serve as an outsourcing resource to the fast growing biological medicines sector.
The project is being part funded by Scottish Enterprise Edinburgh and Lothian. Scottish Enterprise CEO Jack Perry commented: "It is gratifying to see a UK-based company in a key industry for Scotland investing in the future by creating and expanding its business and adding jobs to the economy. This new facility will contribute to Scotland's economy and more specifically will open the door to the biopharmaceutical marketplace which is currently valued at £24 billion and has been growing at an impressive rate over the last five years."
Other news from the department manufacturing
These products might interest you
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Last viewed contents
AEterna Zentaris Announces Completion of Patient Enrollment for Ozarelix Phase II Trial in Benign Prostatic Hyperplasia
Genentech to set up Singapore's first Microbial-Based Biopharmaceutical Manufacturing Facility - Fourth Biologics Facility in Less Than 2 Years Helps Establish Singapore as a Serious Player in Biologics Manufacturing
Arakis completes Phase I trials of AD 337 in fibromyalgia syndrome
ABRAXANE meets primary endpoint in phase 3 trial for advanced non-small cell lung cancer
Oncolytics Biotech Inc. has been granted patent for extracting virus from cell culture
Researchers identify genes linked to chemoresistance
